US Stock MarketDetailed Quotes

Cartesian Therapeutics (RNAC)

Watchlist
  • 6.350
  • +0.420+7.08%
Close Apr 14 16:00 ET
  • 6.350
  • 0.0000.00%
Post 16:10 ET
168.33MMarket Cap-1.26P/E (TTM)

Cartesian Therapeutics (RNAC) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-212.33%-73.94M
-152.96%-17.71M
-213.94%-15.6M
-21.29%-17.52M
-45.18%-23.11M
53.73%-23.67M
69.93%-7M
248.57%13.69M
-45.99%-14.45M
-81.60%-15.92M
Net income from continuing operations
-68.30%-130.3M
-802.92%-92.58M
-48.46%-35.9M
14.82%15.89M
68.83%-17.71M
64.76%-77.42M
94.23%-10.25M
-168.64%-24.18M
221.51%13.84M
-162.31%-56.82M
Operating gains losses
-180.24%-3.7M
-237.02%-707K
90.90%-516K
-116.73%-654K
-131.08%-1.82M
-96.66%4.61M
-99.64%516K
-86.05%-5.67M
161.63%3.91M
43.42%5.85M
Depreciation and amortization
157.08%2.96M
25.10%608K
111.89%606K
200.51%589K
531.69%1.16M
36.54%1.15M
78.68%486K
51.32%286K
11.36%196K
-11.17%183K
Deferred tax
-3,303.14%-9.19M
----
----
----
----
101.51%287K
----
----
----
----
Other non cash items
-86.95%5.13M
262.71%23.32M
8.50%17.09M
-1,749.03%-35.11M
-100.41%-162K
91.80%39.34M
-176.32%-14.33M
4,300.28%15.75M
-438.50%-1.9M
4,790.91%39.81M
Change In working capital
-39.23%-8.06M
-100.04%-3K
-97.95%530K
95.30%-1.51M
-11.19%-7.08M
-216.50%-5.79M
275.12%6.85M
76,008.82%25.81M
-1,068.25%-32.08M
-213.69%-6.37M
-Change in receivables
-103.05%-243K
-107.96%-393K
-101.24%-368K
104.53%1.41M
-119.96%-893K
779.71%7.98M
337.58%4.94M
9,019.52%29.7M
-1,488.72%-31.14M
315.89%4.48M
-Change in prepaid assets
-403.26%-5.3M
-73.17%264K
78.99%-438K
-40.97%706K
-452.91%-5.83M
238.10%1.75M
179.68%984K
-146.75%-2.09M
43.23%1.2M
8,360.00%1.65M
-Change in payables and accrued expense
73.91%-2.52M
-86.39%126K
173.89%1.34M
-109.90%-3.63M
94.91%-359K
-13,343.84%-9.67M
-44.72%926K
-185.28%-1.81M
-294.04%-1.73M
-53.06%-7.06M
-Change in other working capital
----
----
----
----
----
-211.28%-5.85M
--0
--0
37.00%-412K
-159.37%-5.44M
Cash from discontinued investing activities
Operating cash flow
-212.33%-73.94M
-152.96%-17.71M
-213.94%-15.6M
-21.29%-17.52M
-45.18%-23.11M
53.73%-23.67M
69.93%-7M
248.57%13.69M
-45.99%-14.45M
-81.60%-15.92M
Investing cash flow
Cash flow from continuing investing activities
37.61%-5.45M
-38.98%-492K
79.16%-1.29M
-63.52%-2.6M
-78.57%-1.08M
-125.26%-8.74M
-105.45%-354K
-6.2M
-13,125.00%-1.59M
-102.14%-602K
Net PPE purchase and sale
37.61%-5.45M
-38.98%-492K
79.16%-1.29M
-63.52%-2.6M
-78.57%-1.08M
-4,143.69%-8.74M
-453.13%-354K
---6.2M
-13,125.00%-1.59M
-363.08%-602K
Net business purchase and sale
----
----
----
----
----
--0
----
----
----
----
Net investment purchase and sale
----
----
----
----
----
--0
--0
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
37.61%-5.45M
-38.98%-492K
79.16%-1.29M
-63.52%-2.6M
-78.57%-1.08M
-125.26%-8.74M
-105.45%-354K
---6.2M
-13,125.00%-1.59M
-102.14%-602K
Financing cash flow
Cash flow from continuing financing activities
-104.78%-8.06M
-106.64%-52K
-100.03%-38K
-50.00%60K
-118.65%-8.03M
1,381.31%168.43M
-94.44%783K
602.21%124.49M
104.64%120K
28,779.87%43.03M
Net issuance payments of debt
----
----
----
----
----
--0
--0
--0
----
----
Net common stock issuance
--0
--0
----
----
----
2,117.15%124.44M
--0
----
----
----
Net preferred stock issuance
--0
--0
--0
--0
--0
97.53%40M
--0
--0
--0
--40M
Proceeds from stock option exercised by employees
-92.04%323K
-94.11%50K
-91.07%5K
-29.17%85K
-93.96%183K
1,655.84%4.06M
--849K
-31.71%56K
--120K
1,934.23%3.03M
Net other financing activities
-12,593.94%-8.38M
---102K
---43K
---25K
---8.21M
---66K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-104.78%-8.06M
-106.64%-52K
-100.03%-38K
-50.00%60K
-118.65%-8.03M
1,381.31%168.43M
-94.44%783K
602.21%124.49M
104.64%120K
28,779.87%43.03M
Net cash flow
Beginning cash position
173.71%214.28M
-34.30%145.12M
82.30%162.06M
73.77%182.1M
173.71%214.28M
-27.54%78.29M
172.74%220.87M
-22.70%88.9M
-17.82%104.8M
-27.54%78.29M
Current changes in cash
-164.30%-87.45M
-177.74%-18.26M
-112.83%-16.93M
-26.04%-20.06M
-221.48%-32.21M
558.00%136.01M
-142.73%-6.57M
488.15%131.99M
-27.38%-15.91M
35.90%26.51M
Effect of exchange rate changes
314.29%45K
173.33%11K
33.33%-10K
-14.29%12K
740.00%32K
60.38%-21K
-193.75%-15K
25.00%-15K
150.00%14K
76.19%-5K
End cash Position
-40.79%126.87M
-40.79%126.87M
-34.30%145.12M
82.30%162.06M
73.77%182.1M
173.71%214.28M
173.71%214.28M
172.74%220.87M
-22.70%88.9M
-17.82%104.8M
Free cash flow
-142.30%-79.4M
-136.20%-18.2M
-325.47%-16.89M
-25.47%-20.12M
-46.40%-24.18M
36.21%-32.77M
66.99%-7.71M
181.30%7.49M
-61.84%-16.03M
-85.71%-16.52M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -212.33%-73.94M-152.96%-17.71M-213.94%-15.6M-21.29%-17.52M-45.18%-23.11M53.73%-23.67M69.93%-7M248.57%13.69M-45.99%-14.45M-81.60%-15.92M
Net income from continuing operations -68.30%-130.3M-802.92%-92.58M-48.46%-35.9M14.82%15.89M68.83%-17.71M64.76%-77.42M94.23%-10.25M-168.64%-24.18M221.51%13.84M-162.31%-56.82M
Operating gains losses -180.24%-3.7M-237.02%-707K90.90%-516K-116.73%-654K-131.08%-1.82M-96.66%4.61M-99.64%516K-86.05%-5.67M161.63%3.91M43.42%5.85M
Depreciation and amortization 157.08%2.96M25.10%608K111.89%606K200.51%589K531.69%1.16M36.54%1.15M78.68%486K51.32%286K11.36%196K-11.17%183K
Deferred tax -3,303.14%-9.19M----------------101.51%287K----------------
Other non cash items -86.95%5.13M262.71%23.32M8.50%17.09M-1,749.03%-35.11M-100.41%-162K91.80%39.34M-176.32%-14.33M4,300.28%15.75M-438.50%-1.9M4,790.91%39.81M
Change In working capital -39.23%-8.06M-100.04%-3K-97.95%530K95.30%-1.51M-11.19%-7.08M-216.50%-5.79M275.12%6.85M76,008.82%25.81M-1,068.25%-32.08M-213.69%-6.37M
-Change in receivables -103.05%-243K-107.96%-393K-101.24%-368K104.53%1.41M-119.96%-893K779.71%7.98M337.58%4.94M9,019.52%29.7M-1,488.72%-31.14M315.89%4.48M
-Change in prepaid assets -403.26%-5.3M-73.17%264K78.99%-438K-40.97%706K-452.91%-5.83M238.10%1.75M179.68%984K-146.75%-2.09M43.23%1.2M8,360.00%1.65M
-Change in payables and accrued expense 73.91%-2.52M-86.39%126K173.89%1.34M-109.90%-3.63M94.91%-359K-13,343.84%-9.67M-44.72%926K-185.28%-1.81M-294.04%-1.73M-53.06%-7.06M
-Change in other working capital ---------------------211.28%-5.85M--0--037.00%-412K-159.37%-5.44M
Cash from discontinued investing activities
Operating cash flow -212.33%-73.94M-152.96%-17.71M-213.94%-15.6M-21.29%-17.52M-45.18%-23.11M53.73%-23.67M69.93%-7M248.57%13.69M-45.99%-14.45M-81.60%-15.92M
Investing cash flow
Cash flow from continuing investing activities 37.61%-5.45M-38.98%-492K79.16%-1.29M-63.52%-2.6M-78.57%-1.08M-125.26%-8.74M-105.45%-354K-6.2M-13,125.00%-1.59M-102.14%-602K
Net PPE purchase and sale 37.61%-5.45M-38.98%-492K79.16%-1.29M-63.52%-2.6M-78.57%-1.08M-4,143.69%-8.74M-453.13%-354K---6.2M-13,125.00%-1.59M-363.08%-602K
Net business purchase and sale ----------------------0----------------
Net investment purchase and sale ----------------------0--0--0--0--0
Cash from discontinued investing activities
Investing cash flow 37.61%-5.45M-38.98%-492K79.16%-1.29M-63.52%-2.6M-78.57%-1.08M-125.26%-8.74M-105.45%-354K---6.2M-13,125.00%-1.59M-102.14%-602K
Financing cash flow
Cash flow from continuing financing activities -104.78%-8.06M-106.64%-52K-100.03%-38K-50.00%60K-118.65%-8.03M1,381.31%168.43M-94.44%783K602.21%124.49M104.64%120K28,779.87%43.03M
Net issuance payments of debt ----------------------0--0--0--------
Net common stock issuance --0--0------------2,117.15%124.44M--0------------
Net preferred stock issuance --0--0--0--0--097.53%40M--0--0--0--40M
Proceeds from stock option exercised by employees -92.04%323K-94.11%50K-91.07%5K-29.17%85K-93.96%183K1,655.84%4.06M--849K-31.71%56K--120K1,934.23%3.03M
Net other financing activities -12,593.94%-8.38M---102K---43K---25K---8.21M---66K----------------
Cash from discontinued financing activities
Financing cash flow -104.78%-8.06M-106.64%-52K-100.03%-38K-50.00%60K-118.65%-8.03M1,381.31%168.43M-94.44%783K602.21%124.49M104.64%120K28,779.87%43.03M
Net cash flow
Beginning cash position 173.71%214.28M-34.30%145.12M82.30%162.06M73.77%182.1M173.71%214.28M-27.54%78.29M172.74%220.87M-22.70%88.9M-17.82%104.8M-27.54%78.29M
Current changes in cash -164.30%-87.45M-177.74%-18.26M-112.83%-16.93M-26.04%-20.06M-221.48%-32.21M558.00%136.01M-142.73%-6.57M488.15%131.99M-27.38%-15.91M35.90%26.51M
Effect of exchange rate changes 314.29%45K173.33%11K33.33%-10K-14.29%12K740.00%32K60.38%-21K-193.75%-15K25.00%-15K150.00%14K76.19%-5K
End cash Position -40.79%126.87M-40.79%126.87M-34.30%145.12M82.30%162.06M73.77%182.1M173.71%214.28M173.71%214.28M172.74%220.87M-22.70%88.9M-17.82%104.8M
Free cash flow -142.30%-79.4M-136.20%-18.2M-325.47%-16.89M-25.47%-20.12M-46.40%-24.18M36.21%-32.77M66.99%-7.71M181.30%7.49M-61.84%-16.03M-85.71%-16.52M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
At 22:00 Beijing time on April 13, the US Central Command officially blocked maritime traffic at Iranian ports, imposing the strictest sanct Show More